Literature DB >> 10898680

Antibacterial action of structurally diverse cationic peptides on gram-positive bacteria.

C L Friedrich1, D Moyles, T J Beveridge, R E Hancock.   

Abstract

Antimicrobial cationic peptides are ubiquitous in nature and are thought to be a component of the first line of defense against infectious agents. It is widely believed that the killing mechanism of these peptides on bacteria involves an interaction with the cytoplasmic membrane. Cationic peptides from different structural classes were used in experiments with Staphylococcus aureus and other medically important gram-positive bacteria to gain insight into the mechanism of action. The membrane potential-sensitive fluorophore dipropylthiacarbocyanine was used to assess the interactions of selected antimicrobial peptides with the cytoplasmic membrane of S. aureus. Study of the kinetics of killing and membrane depolarization showed that, at early time points, membrane depolarization was incomplete, even when 90% or more of the bacteria had been killed. CP26, a 26-amino-acid alpha-helical peptide with a high MIC against S. aureus, still had the ability to permeabilize the membrane. Cytoplasmic-membrane permeabilization was a widespread ability and an action that may be necessary for reaching an intracellular target but in itself did not appear to be the killing mechanism. Transmission electron microscopy of S. aureus and Staphylococcus epidermidis treated with CP29 (a 26-amino-acid alpha-helical peptide), CP11CN (a 13-amino-acid, proline- and tryptophan-rich peptide), and Bac2A-NH(2) (a linearized version of the 12-amino-acid loop peptide bactenecin) showed variability in effects on bacterial structure. Mesosome-like structures were seen to develop in S. aureus, whereas cell wall effects and mesosomes were seen with S. epidermidis. Nuclear condensation and abherrent septation were occasionally seen in S. epidermidis. Our experiments indicated that these peptides vary in their mechanisms of action and that the mechanism of action likely does not solely involve cytoplasmic-membrane permeabilization.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10898680      PMCID: PMC90018          DOI: 10.1128/AAC.44.8.2086-2092.2000

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  33 in total

1.  Antibacterial peptides designed as analogs or hybrids of cecropins and melittin.

Authors:  D Wade; D Andreu; S A Mitchell; A M Silveira; A Boman; H G Boman; R B Merrifield
Journal:  Int J Pept Protein Res       Date:  1992-11

Review 2.  Cationic bactericidal peptides.

Authors:  R E Hancock; T Falla; M Brown
Journal:  Adv Microb Physiol       Date:  1995       Impact factor: 3.517

3.  Magainin 2 amide and analogues. Antimicrobial activity, membrane depolarization and susceptibility to proteolysis.

Authors:  D Juretić; H C Chen; J H Brown; J L Morell; R W Hendler; H V Westerhoff
Journal:  FEBS Lett       Date:  1989-06-05       Impact factor: 4.124

4.  Insect defensin, an inducible antibacterial peptide, forms voltage-dependent channels in Micrococcus luteus.

Authors:  S Cociancich; A Ghazi; C Hetru; J A Hoffmann; L Letellier
Journal:  J Biol Chem       Date:  1993-09-15       Impact factor: 5.157

5.  Proton motive force may regulate cell wall-associated enzymes of Bacillus subtilis.

Authors:  M A Kemper; M M Urrutia; T J Beveridge; A L Koch; R J Doyle
Journal:  J Bacteriol       Date:  1993-09       Impact factor: 3.490

6.  Indolicidin, a novel bactericidal tridecapeptide amide from neutrophils.

Authors:  M E Selsted; M J Novotny; W L Morris; Y Q Tang; W Smith; J S Cullor
Journal:  J Biol Chem       Date:  1992-03-05       Impact factor: 5.157

7.  The interaction of a recombinant cecropin/melittin hybrid peptide with the outer membrane of Pseudomonas aeruginosa.

Authors:  K L Piers; R E Hancock
Journal:  Mol Microbiol       Date:  1994-06       Impact factor: 3.501

8.  Interaction of macrophage cationic proteins with the outer membrane of Pseudomonas aeruginosa.

Authors:  J G Sawyer; N L Martin; R E Hancock
Journal:  Infect Immun       Date:  1988-03       Impact factor: 3.441

9.  Morphology of defensin-treated Staphylococcus aureus.

Authors:  M Shimoda; K Ohki; Y Shimamoto; O Kohashi
Journal:  Infect Immun       Date:  1995-08       Impact factor: 3.441

10.  Ultrastructural alterations of bacteria during the postantibiotic effect.

Authors:  M Gottfredsson; H Erlendsdóttir; R Kolka; A Gudmundsson; S Gudmundsson
Journal:  Chemotherapy       Date:  1993 May-Jun       Impact factor: 2.544

View more
  123 in total

1.  Designing surfaces that kill bacteria on contact.

Authors:  J C Tiller; C J Liao; K Lewis; A M Klibanov
Journal:  Proc Natl Acad Sci U S A       Date:  2001-05-15       Impact factor: 11.205

2.  Damage of the bacterial cell envelope by antimicrobial peptides gramicidin S and PGLa as revealed by transmission and scanning electron microscopy.

Authors:  Mareike Hartmann; Marina Berditsch; Jacques Hawecker; Mohammad Fotouhi Ardakani; Dagmar Gerthsen; Anne S Ulrich
Journal:  Antimicrob Agents Chemother       Date:  2010-06-07       Impact factor: 5.191

3.  Omiganan pentahydrochloride (MBI 226), a topical 12-amino-acid cationic peptide: spectrum of antimicrobial activity and measurements of bactericidal activity.

Authors:  Helio S Sader; Kelley A Fedler; Robert P Rennie; Shelley Stevens; Ronald N Jones
Journal:  Antimicrob Agents Chemother       Date:  2004-08       Impact factor: 5.191

4.  Quality control guidelines for MIC susceptibility testing of omiganan pentahydrochloride (MBI 226), a novel antimicrobial peptide.

Authors:  Tamara R Anderegg; Thomas R Fritsche; Ronald N Jones
Journal:  J Clin Microbiol       Date:  2004-03       Impact factor: 5.948

5.  Short cationic antimicrobial peptides interact with ATP.

Authors:  Kai Hilpert; Brett McLeod; Jessie Yu; Melissa R Elliott; Marina Rautenbach; Serge Ruden; Jochen Bürck; Claudia Muhle-Goll; Anne S Ulrich; Sandro Keller; Robert E W Hancock
Journal:  Antimicrob Agents Chemother       Date:  2010-07-26       Impact factor: 5.191

6.  Permeabilization of fungal hyphae by the plant defensin NaD1 occurs through a cell wall-dependent process.

Authors:  Nicole L van der Weerden; Robert E W Hancock; Marilyn A Anderson
Journal:  J Biol Chem       Date:  2010-09-22       Impact factor: 5.157

7.  Ultrashort peptide bioconjugates are exclusively antifungal agents and synergize with cyclodextrin and amphotericin B.

Authors:  Christopher J Arnusch; Hannah Ulm; Michaele Josten; Yana Shadkchan; Nir Osherov; Hans-Georg Sahl; Yechiel Shai
Journal:  Antimicrob Agents Chemother       Date:  2011-10-17       Impact factor: 5.191

8.  Structure-function characterization and optimization of a plant-derived antibacterial peptide.

Authors:  Mougli Suarez; Marisa Haenni; Stéphane Canarelli; Florian Fisch; Pierre Chodanowski; Catherine Servis; Olivier Michielin; Ruth Freitag; Philippe Moreillon; Nicolas Mermod
Journal:  Antimicrob Agents Chemother       Date:  2005-09       Impact factor: 5.191

Review 9.  [Antibacterial photodynamic therapy. A new treatment for superficial bacterial infections?].

Authors:  T Maisch; R-M Szeimies; N Lehn; C Abels
Journal:  Hautarzt       Date:  2005-11       Impact factor: 0.751

10.  Fast disinfecting antimicrobial surfaces.

Authors:  Ahmad E Madkour; Jeffery M Dabkowski; Klaus Nusslein; Gregory N Tew
Journal:  Langmuir       Date:  2009-01-20       Impact factor: 3.882

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.